Who owns the GENE REWRITING trademark?

The GENE REWRITING trademark is owned by Tessera Therapeutics, Inc..

What class is the GENE REWRITING trademark registered in?

The GENE REWRITING trademark is registered in Class 042 (Scientific, technology & SaaS services).

What is the serial number for GENE REWRITING?

The USPTO serial number for GENE REWRITING is 88921526.

What is the registration number for GENE REWRITING?

GENE REWRITING is registered under USPTO registration number 0.

Sealvo

Home Search: GENE REWRITINGGENE REWRITING #88921526

Back

Updated Sep 29, 2026·28 searches this week

View on USPTO TSDR Find similar marks

GEN

USPTO Trademark Record

ABANDONED

GENE REWRITING

SN 88921526·Reg 0·Filed May 18, 2020

Owner Tessera Therapeutics, Inc.

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

GENE REWRITING (Serial No. 88921526), Registration No. 0, is a abandoned US trademark filed on May 18, 2020 by Tessera Therapeutics, Inc.. This trademark covers Class 042 (Scientific, technology & SaaS services).

Conflict Analysis

Full conflict analysis for GENE REWRITING (SN 88921526) against the USPTO database with detailed risk factor explanations. AI-powered — takes ~1-2 min.

Mark Intelligence

GENE REWRITING (Reg. #0) is an abandoned US trademark that was filed in 2020 but has since been abandoned. The mark covers Class 042 (Scientific, technology & SaaS services). Goods and services include Scientific and technological services and research and design relating thereto; industrial analysis, industrial research....

FILED

May 18, 2020

SERIAL

88921526

REG#

REGISTERED

Dec 31, 1969

Filing Information

StatusABANDONED

Filing DateMay 18, 2020

Serial Number88921526

Registration No.0

Registration DateDec 31, 1969

Status DateAug 21, 2023

Mark TypeStandard characters

Filing Basis & Declarations

Standard Characters ClaimedUse Application Currently

International Filings

Madrid Protocol1 filings

This mark has 1 Madrid Protocol filing on record with the USPTO.

1569347

499Nov 17, 2020

Source: USPTO Madrid International Filing Requests

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 042Scientific, technology & SaaS services

US codes: 100, 101

First use anywhere: Sep 07, 2021

First use in commerce: Sep 07, 2021

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

44 events

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND

Aug 21, 2023

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND

ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE

Aug 21, 2023

ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE

ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND

Aug 21, 2023

ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

Apr 21, 2023

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

Apr 21, 2023

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Apr 06, 2023

TEAS CHANGE OF CORRESPONDENCE RECEIVED

TEAS CHANGE OF OWNER ADDRESS RECEIVED

Apr 06, 2023

TEAS CHANGE OF OWNER ADDRESS RECEIVED

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

Apr 06, 2023

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

SUBSEQUENT FINAL EMAILED

Jan 24, 2023

SUBSEQUENT FINAL EMAILED

NOTIFICATION OF SUBSEQUENT FINAL EMAILED

Jan 24, 2023

NOTIFICATION OF SUBSEQUENT FINAL EMAILED

SUBSEQUENT FINAL REFUSAL WRITTEN

Jan 24, 2023

SUBSEQUENT FINAL REFUSAL WRITTEN

TEAS/EMAIL CORRESPONDENCE ENTERED

Dec 13, 2022

TEAS/EMAIL CORRESPONDENCE ENTERED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Dec 13, 2022

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Dec 13, 2022

CORRESPONDENCE RECEIVED IN LAW OFFICE

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Jun 13, 2022

NOTIFICATION OF NON-FINAL ACTION E-MAILED

NON-FINAL ACTION E-MAILED

Jun 13, 2022

NON-FINAL ACTION E-MAILED

NON-FINAL ACTION WRITTEN

Jun 13, 2022

NON-FINAL ACTION WRITTEN

TEAS/EMAIL CORRESPONDENCE ENTERED

Apr 19, 2022

TEAS/EMAIL CORRESPONDENCE ENTERED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Apr 18, 2022

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Apr 18, 2022

TEAS RESPONSE TO OFFICE ACTION RECEIVED

NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED

Oct 19, 2021

NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED

NON-FINAL ACTION E-MAILED

Oct 16, 2021

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Oct 16, 2021

NOTIFICATION OF NON-FINAL ACTION E-MAILED

USE AMENDMENT ACCEPTED

Oct 16, 2021

USE AMENDMENT ACCEPTED

NON-FINAL ACTION WRITTEN

Oct 16, 2021

NON-FINAL ACTION WRITTEN

TEAS/EMAIL CORRESPONDENCE ENTERED

Sep 15, 2021

TEAS/EMAIL CORRESPONDENCE ENTERED

USE AMENDMENT FILED

Sep 15, 2021

USE AMENDMENT FILED

AMENDMENT TO USE PROCESSING COMPLETE

Sep 15, 2021

AMENDMENT TO USE PROCESSING COMPLETE

TEAS AMENDMENT OF USE RECEIVED

Sep 14, 2021

TEAS AMENDMENT OF USE RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Sep 14, 2021

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS REQUEST FOR RECONSIDERATION RECEIVED

Sep 14, 2021

TEAS REQUEST FOR RECONSIDERATION RECEIVED

FINAL REFUSAL E-MAILED

Mar 15, 2021

FINAL REFUSAL E-MAILED

FINAL REFUSAL WRITTEN

Mar 15, 2021

FINAL REFUSAL WRITTEN

NOTIFICATION OF FINAL REFUSAL EMAILED

Mar 15, 2021

NOTIFICATION OF FINAL REFUSAL EMAILED

TEAS/EMAIL CORRESPONDENCE ENTERED

Feb 19, 2021

TEAS/EMAIL CORRESPONDENCE ENTERED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Feb 18, 2021

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Feb 18, 2021

TEAS RESPONSE TO OFFICE ACTION RECEIVED

EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED

Aug 19, 2020

EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED

NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED

Aug 19, 2020

NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED

COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY

Aug 19, 2020

COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY

EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED

Aug 19, 2020

EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED

ASSIGNED TO EXAMINER

Aug 16, 2020

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Jun 03, 2020

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

May 21, 2020

NEW APPLICATION ENTERED

Other Marks by Tessera Therapeutics, Inc.

Additional USPTO filings from the same owner.

LOG

LogoMark

88818421

Tessera Therapeutics, Inc.

REGISTERED

TES

TESSERA

88642455

TESSERA THERAPEUTICS, INC.

REGISTERED

GEN

GENE REWRITER

98737788

Tessera Therapeutics, Inc.

PENDING

GEN

GENE WRITER

98614889

Tessera Therapeutics, Inc.

PENDING

Other Marks in Class 042 — Scientific, technology & SaaS services

Recently filed and registered marks in the same international class.

GEN

GENE-RADAR

78523874

NANOBIOSYM, INC.

REGISTERED

GEN

GENE & GEORGETTI

74560347

G & G 500, LLC

REGISTERED

GEN

GENE-FORECAST

86289131

U.S. Department of Health and Human Services

REGISTERED

GEN

GENE-RADAR

97574644

Nanobiosym, Inc

REGISTERED

Other Marks by Christina M. Licursi

Additional USPTO filings handled by the same attorney of record.

EXP

EXPEDITION

98978174

REGISTERED

TRU

TRUPREP

98178281

REGISTERED

YAL

YALE

74489560

REGISTERED

A2B

86454366

REGISTERED

GENE REWRITING

Run a conflict check

Other Marks by Tessera Therapeutics, Inc.

Other Marks in Class 042 — Scientific, technology & SaaS services

Other Marks by Christina M. Licursi

Get pre-filing clearance

Search 15M+ trademarks

Resources

Company